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The peripheral chemoreflex increases both parasympathetic and sympathetic drive under chronic 6 hypoxia. We found that this evoked brady-arrhythmias when combined with apneic periods in 7 Lowlanders at altitude, which become relieved through supplemental oxygen. In contrast high altitude 8 residents (Nepalese Sherpa) do not exhibit brady-arrhythmias during apnea at altitude through 9 potential cardio-protective adaptations. The degree of bradycardia and brady-arrhythmias was related 10 to the hypoxic ventilatory response, demonstrating that the chemoreflex plays an important role in 11 these findings.
INTRODUCTION

52
It has been traditionally shown that efferent sympathetic and vagal outflow to the heart is reciprocal, 53 through which increased activation of one pathway sees a respective decrease in the other (17) . As such, 54 the variation of cardiac sinus conduction is controlled through the balance between neural outflows in 55 healthy populations. Concurrent increases in both pathways can occur under specific circumstances, and 56 has previously referred to as cardiac "autonomic conflict" (29). This has previously been previously 57 reported during periods of considerable autonomic stress (e.g. cold water submersion) due to conflicting 58 activation of both sympathetic and parasympathetic pathways, ultimately promoting cardiac 59 arrhythmogenesis in healthy individuals (8, 33) . In addition, conflict can be seen to some degree in 60 clinical populations suffering from sleep apnea, where elevated chemoreflex gain during apneic periods 61 being is linked to both hypertensive and bradycardia responses (24, 30 ). Yet the degree of conflict can be 62 considered minimal, with no previous accounts of arrhythmogenesis being noted in healthy populations 63 exhibiting normal chemoreflex function during apnea (e.g. volitional breath holding).
65
Heightened chemoreflex activity under chronic hypoxia results in a concurrent increase of efferent 66 peripheral sympathetic nerve activity and cardiac vagal tone (9). However these increases are normally 67 dampened by the inhibitor influence of pulmonary stretch receptors, ultimately blunting sympathetic 68 outflow to heightened chemoreflex stress (19, 28, 31) . As such, there is limited electrocardiographic 69 evidence that suggests chronic hypoxia exposure leads to incidences of bradycardic arrhythmia within 70 healthy individuals during sleep (4). The peripheral chemoreflex has been implicated specifically in these 71 cases as the changes in heart rate observed appear correlated to the ventilatory response to acute hypoxia 72 (22). Thus, there is a mechanistic basis for hypothesizing that chemoreflex sensitization during 73 acclimatization at altitude (10) may promote autonomic conflict and potential bradycardic arrhythmic 74 events during periods of sleep-related apnea. The use of voluntary apnea during chronic altitude exposure 75 is therefore a relevant experimental model to investigate autonomic cardiac function independent of 76 underlying comorbidities.
Resting Baseline and Apnea Protocol
104
Pre-expedition testing (Lowlanders) was conducted at 344m (Kelowna, Canada). After flying to 105 2840m participants followed a conservative ascent profile (9-10 days) to the EV-K2-CNR research 106 facility (5050m; Nepal). Two Lowlanders were administered medication for treatment of altitude illness 107 during ascent (a single dose of acetazolamide (125mg) or dexamethasone), but were tested following a 108 minimum 48hr washout period. Sherpa were tested on days 1-4 and Lowlanders were tested after 4-10 109 days at 5050m. Both Sherpa and Lowlanders exhibited similar resting peripheral oxygen saturation (SpO 2, 110 82% and 83% respectively) at 5050m.
112
Participants were tested in the supine position. ECG (Lead II) and arterial blood pressure (finger 113 photoplethysmography; Finometer Pro, Finapres Medical Systems, Netherlands) were collected 114 continuously at 1KHz (ADInstruments, Chart Pro v8.3.1). Brachial arterial pressure waveform was back 115 calibrated through return to flow (RTF) correction confirmed against manual brachial measurements.
116
Mean (MAP), systolic (SBP) and diastolic (DBP) pressures were calculated on a beat-by-beat basis from 117 the calibrated pressure waveform. Beat-by-beat cardiac output (CO) was calculated using the Model Flow 118 algorithm and used to calculate total peripheral resistance (TPR = MAP/CO). SPO 2 was continually 119 assessed (pulse oximetry; Nellcor, Medtronics,USA). Following 10 minutes of quiet baseline measures 120 participants were instructed to perform an end-expiratory apnea (at functional residual capacity). An 
170
All 14 Lowlanders were successfully tested at 344m and 5050m. No sex differences were present 171 between the 2 females in the Lowlander group. Prior to testing one Lowlander was categorized as having 172 mild acute mountain sickness at altitude (Lake Louise score 3), but no other participants exhibited 173 symptoms of illness.
175
Group characteristics and cardiovascular function for each condition are reported in Table 1 . HR 176 increased in Lowlanders at high altitude (p<0.05 vs. low altitude); becoming similar to Sherpas. SBP, (Table 2) . Sherpas also exhibited widened QRS complexes (P<0.001) and longer QTc 188 (P<0.05) at altitude compared to Lowlanders at low altitude ( Table 2 ). The incidence of arrhythmia at 189 rest was low in all groups and conditions (Table 3) . One Lowlander exhibited periodic premature 190 ventricular contractions during rest at both altitudes, but the incidence remained low (<2/min) and 191 unchanged between altitudes. Upon accent to altitude one Lowlander developed persistent junctional 192 rhythm that was not relieved with oxygen. No arrhythmias were noted in Sherpa at rest.
194
Lowlanders saw no difference in indices of HRV (SDNN, RMSDD, and total power) between 195 low and high altitude with exception to RRI, which became significantly decreased (1157± 240ms versus 196 979±208 ms; P<0.001) at high altitude. However, oxygen supplementation did not relieve SDNN,
197
RMSDD, total power, and RRI at altitude. Sherpas did not exhibit any difference in HRV measures to 198 Lowlanders at high altitude. For all groups/altitude there was no difference in frequencies (VLF, LF, and 199 HV) and total power. However, Lowlanders exhibited a significant increase in the LF/HF ratio at high Table 3 ). In contrast, no abnormalities were apparent during As HVR was similar between groups (see above), including the one female participant, data were 235 combined to assess the relationship between HVR and heart rhythm. The gain of the bradycardic 236 response during apnea across groups was correlated with HVR ( Figure 3) . Two Lowlanders were 237 identified as statistical outliers using studentized residuals; however, the relationship remained significant 238 when these individuals were either included or removed from the analysis (Figure 3 ). When data were 239 grouped based on the presence or absence of arrhythmia during apnea, those individuals exhibiting apneas 240 had significantly higher HVRs (Median 0.66 L/min) vs. those that did not exhibit arrhythmias (Median 241 0.26, P<0.02; Figure 4a ). ROC analysis further indicated that HVR was significantly predictive of the 242 incidence of arrhythmia during apnea (AUC = 0.86, P<0.05; Figure 4b ) with a sensitivity of 75% and 243 specificity of 78% when using an optimized HVR cutoff of 0.40 L/min (Figure 4c ). However, there was 244 no relationship between HVR and the magnitude of bradycardia during apnea (R 2 = 0.08). 
252
Supplementation of oxygen returned R-wave amplitude to low altitude values and the incidence of 253 arrhythmia was significantly reduced compared to euoxic apnea (3 of 7 Lowlanders, p<0.05; Table 3 ).
DISCUSSION
257
In the current study we have demonstrated that through the use of voluntary apnea at altitude, there 277 Lowlanders using continuous ECG monitoring. In both reports, arrhythmia incidence was increased at 278 higher altitudes (5000-7550m) as well as with longer exposure periods (4, 34). Both our data and these 279 previous findings suggest high altitude to be a "pro-arrhythmia" environment, where the influence of 280 hypoxia may be compounded further during periods of stress. Although we did not obtain continuous (23, 35 ). In the current study we have 301 demonstrated a similar "autonomic conflict" that is unmasked during apnea and mediated via the 302 peripheral chemoreflex. Firstly, we showed that the bradycardia associated with apnea at altitude was 303 correlated with the hypoxic ventilatory response. Secondly, oxygen administration prior to apnea at 304 altitude eliminated bradycardia and reduced the incidence of arrhythmia to the same level as observed at 305 low altitude.
Although Sherpas had a similar breath hold duration and resting arterial oxygen saturation; they 308 did not exhibit significant bradycardia or any arrhythmias. Previous data from native Tibetans indicate a 309 normal ECG compared Han residents who had migrated during childhood to high altitude (13). We saw 310 that breath holding generated arrhythmias in most Lowlanders but not Sherpa. Thus, these findings 311 suggest that Sherpa exhibit an altered cardiac response to hypoxic stress. However, it is unclear what the 312 specific nature of the adaptation that might be present. We do not believe this is related to differences in 313 chemoreflex sensitivity as our findings are consistent with recent data indicating Sherpas to have similar 314 chemoreflex sensitivity to acclimatized Lowlanders (7, 12, 36 ). Yet when Lowlanders and Sherpa were 315 considered together, we found that high altitude HVR was significantly related to the normalized 
337
We demonstrate a relationship between the HVR and degree of bradycardic response at altitude.
338
However, we acknowledge that two individuals with high HVRs (statistically identified as outliers in 339 relation to the rest of our participants) appear to weight this relationship. However, even if these two 340 participants were removed, there still existed a significant relationship between HVR and bradycardic 341 response (see figure 3 ). We acknowledge that our measure of HVR may exhibit some degree of 
